[ASAP] Optimizing a Weakly Binding Fragment into a Potent ROR?t Inverse Agonist with Efficacy in an in Vivo Inflammation Model

David A. Carcache, Anna Vulpetti, Joerg Kallen, Henri Mattes, David Orain, Rowan Stringer, Eric Vangrevelinghe, Romain M. Wolf, Klemens Kaupmann, Johannes Ottl, Janet Dawson, Nigel G. Cooke, Klemens Hoegenauer, Andreas Billich, Juergen Wagner, Christine Guntermann, Samuel Hintermann
American Chemical Society (ACS)
Published 2018